HI TECH PHARMACAL CO INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 27 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-13: Reporting owner April Gary M; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-13: Reporting owner April Gary M; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-13: Reporting owner April Gary M; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-10-10: Reporting owner SELTZER REUBEN; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-13 | April Gary M Officer (President, HCP Division) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,875 0 owned after | $19.59 exercise price | 2013-12-17 | |
| 2013-12-13 | April Gary M Officer (President, HCP Division) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,874 1,876 owned after | $22.25 exercise price | 2013-12-17 | |
| 2013-12-13 | April Gary M Officer (President, HCP Division) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,124 9,376 owned after | $31.93 exercise price | 2013-12-17 | |
| 2013-10-10 | SELTZER REUBEN Director, Officer (Vice Chairman, Business Dev't) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,250 0 owned after | $10.93 exercise price | 2013-10-10 | |
| 2013-10-09 | SELTZER DAVID S Director, Officer (CEO, President, Sec'y, Treas.), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,000 0 owned after | $14.99 exercise price | 2013-10-10 | |
| 2013-10-04 | GOLDWYN MARTIN M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 7,875 owned after | $24.95 exercise price | 2013-10-08 | |
| 2013-10-03 | PETERS WILLIAM J Officer (EVP & Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 3,750 owned after | $18.87 exercise price | 2013-10-04 | |
| 2013-10-03 | PETERS WILLIAM J Officer (EVP & Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,250 0 owned after | $5.83 exercise price | 2013-10-04 | |
| 2013-10-02 | SELTZER REUBEN Director, Officer (Vice Chairman, Business Dev't) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,250 0 owned after | $13.50 exercise price | 2013-10-04 | |
| 2013-10-01 | Simpson Bruce W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,375 0 owned after | $24.95 exercise price | 2013-10-04 | |
| 2013-10-01 | Simpson Bruce W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,093 0 owned after | $5.83 exercise price | 2013-10-04 | |
| 2013-10-01 | Simpson Bruce W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $19.59 exercise price | 2013-10-04 | |
| 2013-10-01 | Simpson Bruce W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 5,000 owned after | $22.25 exercise price | 2013-10-04 | |
| 2013-10-01 | Simpson Bruce W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 7,500 owned after | $32.59 exercise price | 2013-10-04 | |
| 2013-09-30 | GOLDWYN MARTIN M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,111 0 owned after | $13.50 exercise price | 2013-10-01 | |
| 2013-09-30 | April Gary M Officer (President, HCP Division) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,125 9,375 owned after | $32.59 exercise price | 2013-10-01 | |
| 2013-09-27 | GOLDWYN MARTIN M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,308 3,111 owned after | $13.50 exercise price | 2013-10-01 | |
| 2013-09-27 | GOLDWYN MARTIN M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 9,375 owned after | $24.95 exercise price | 2013-10-01 | |
| 2013-09-17 | HIRSHAUT YASHAR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,250 0 owned after | $13.50 exercise price | 2013-10-04 | |
| 2013-06-13 holding as of filing | SELTZER REUBEN Director, Officer (Vice Chairman-Business Dev't) | 5 | Stock Option (Right to Buy) Derivative · Direct | Holding | 326,250 owned after | no price filed | 2013-06-13 | |
| 2013-05-22 | Egbaria Kamel Officer (Chief Scientific Officer, EVP) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $33.81 exercise price | 2013-05-24 | |
| 2013-03-11 | Durrant Cameron Other (President, CEO of ECR Pharm.) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $35.36 exercise price | 2013-03-13 | |
| 2013-02-05 | PETERS WILLIAM J Officer (VP and Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36 12,500 owned after | $10.68 exercise price | 2013-02-05 | |
| 2013-02-01 | PETERS WILLIAM J Officer (VP and Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,603 12,536 owned after | $10.68 exercise price | 2013-02-05 | |
| 2013-01-24 | PETERS WILLIAM J Officer (VP and Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,250 0 owned after | $10.68 exercise price | 2013-01-28 | |
| 2013-01-24 | PETERS WILLIAM J Officer (VP and Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,611 17,139 owned after | $10.68 exercise price | 2013-01-28 | |
| 2013-01-09 | SELTZER DAVID S Director, Officer (CEO, President, Sec'y, Treas.), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −112,500 0 owned after | $11.56 exercise price | 2013-01-11 |